EMA — authorised 8 September 2003
- Marketing authorisation holder: AbbVie Deutschland GmbH Co. KG
- Status: approved
🇪🇺 Abrilada in European Union
EMA authorised Abrilada on 8 September 2003
Marketing authorisation
Abrilada in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Abrilada approved in European Union?
Yes. EMA authorised it on 8 September 2003.
Who is the marketing authorisation holder for Abrilada in European Union?
AbbVie Deutschland GmbH Co. KG holds the EU marketing authorisation.